Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Second-line or Subsequent Systemic Therapy for...
Journal article

Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline

Authors

Noble J; Ellis PM; Mackay JA; Evans WK

Journal

Journal of Thoracic Oncology, Vol. 1, No. 9, pp. 1042–1058

Publisher

Elsevier

Publication Date

November 2006

DOI

10.1097/01243894-200611000-00021

ISSN

1556-0864

Associated Experts

Peter Ellis

Professor, Faculty of Health Sciences
Visit profile

William Evans

Professor Emeritus, Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences3211 Oncology and carcinogenesis3202 Clinical sciences

Medical Subject Headings (MeSH)

Antineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell LungClinical Trials, Phase III as TopicDocetaxelDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHumansInfusions, IntravenousLung NeoplasmsMaleMaximum Tolerated DoseNeoplasm Recurrence, LocalNeoplasm StagingOntarioPalliative CarePractice Guidelines as TopicQuality of LifeRandomized Controlled Trials as TopicRisk AssessmentSurvival AnalysisTaxoidsTime Factors
View published work (Non-McMaster Users)
View published work (McMaster Users)